Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Decoster, L. [1 ]
Nazari, S. [2 ]
De Ridder, K. [3 ]
Giron, P. [4 ]
Vekens, K. [5 ]
Goyvaerts, C. [6 ]
机构：
[1] UZ Brussel Univ Ziekenhuis Brussel, Dept Med Oncol, Jette, Belgium
[2] Vrije Univ Brussel, Med Oncol, Fac Med & Pharm, Brussels, Belgium
[3] Vrije Univ Brussel, Dept Biomed Sci, Lab Mol & Cellular Therapy, Fac Med & Pharm, Brussels, Belgium
[4] UZ Brussel Univ Ziekenhuis Brussel, Dept Clin Genet, Jette, Belgium
[5] UZ Brussel Univ Ziekenhuis Brussel, Div Resp, Jette, Belgium
[6] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Fac Med & Pharm, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1096P
引用
收藏
页码：S1052 / S1052
页数：1
相关论文
共 50 条
  • [41] Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging
    Monkman, James
    Moradi, Afshin
    Yunis, Joseph
    Ivison, Geoff
    Mayer, Aaron
    Ladwa, Rahul
    O'Byrne, Ken
    Kulasinghe, Arutha
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [42] The influence of circulating tumor DNA analysis on response to immunotherapy in non-small cell lung cancer (NSCLC)
    Grinberg, R.
    Roisman, L. C.
    Geva, S.
    Soussan-Gutman, L.
    Dvir, A.
    Yair, R.
    Twito, T.
    Larman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S35 - S36
  • [43] Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)
    Bodor, J. Nicholas
    Boumber, Yanis
    Borghaei, Hossein
    CANCER, 2020, 126 (02) : 260 - 270
  • [44] The Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
    Grinberg, R.
    Roisman, L.
    Geva, S.
    Lefterova, M.
    Quinn, K.
    Gutman, L. Soussan
    Dvir, A.
    Yair, R.
    Twito, T.
    Lanman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S925 - S926
  • [45] Multi-omic dissection of immunotherapy response groups in non-small cell lung cancer (NSCLC)
    Kulasinghe, Arutha
    Monkman, James
    Kim, Honesty
    Mayer, Aaron
    Mehdi, Ahmed
    Matigian, Nicholas
    Cumberbatch, Marie
    Bhagat, Milan
    Ladwa, Rahul
    Mueller, Scott
    Adams, Mark
    O'Byrne, Ken
    CANCER RESEARCH, 2022, 82 (12)
  • [46] The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
    Fang, Rui
    Zhu, Yong
    Khadka, Vedbar S.
    Zhang, Fan
    Jiang, Bin
    Deng, Youping
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [47] miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC)
    Han, Yichao
    Li, Hecheng
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 3119 - 3131
  • [48] Biomarkers for targeted therapy selection in non-small cell lung cancer (NSCLC)
    Paz-Ares, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S4 - S4
  • [49] Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
    Guo, Shicheng
    Yan, Fengyang
    Xu, Jibin
    Bao, Yang
    Zhu, Ji
    Wang, Xiaotian
    Wu, Junjie
    Li, Yi
    Pu, Weilin
    Liu, Yan
    Jiang, Zhengwen
    Ma, Yanyun
    Chen, Xiaofeng
    Xiong, Momiao
    Jin, Li
    Wang, Jiucun
    Clinical Epigenetics, 2015, 7 : 2 - 9
  • [50] Exhaled Breath Biomarkers of Response to Immunotherapy in Advanced Non-Small Lung Cancer
    Reilly, D. E. O.
    Dowling, G.
    Marks, S.
    Barry, S.
    Moloney, C.
    Moran, L.
    Kieran, R.
    Cluxton, C.
    Moyle, J.
    Reilly, A.
    Deac, O.
    McNevin, C.
    Hadi, D.
    Dillon, R.
    Kirwan, L.
    Barr, M. P.
    Cuffe, S.
    Toomey, S.
    Hennessy, B.
    Naidoo, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S253 - S254
12345